Bill aims to establish regulatory framework for CBD as a supplement
Senator Ron Wyden (D-OR) has reintroduced a bill that aims to establish US Food and Drug Administration (FDA) regulatory framework for CBD as a dietary supplement or food and beverage additive.
Alongside Sens. Rand Paul (R-KY) and Jeff Merkley (D-OR), Wyden announced the reintroduction of The Hemp Access and Consumer Safety Act.
The U.S. Hemp Roundtable has said that it strongly endorses this legislation and applauds Sen. Wyden and his Congressional colleagues for championing efforts to regulate CBD products in the Senate.
Jonathan Miller, General Counsel of the U.S. Hemp Roundtable stated: “We commend Senator Ron Wyden for reintroducing The Hemp Access and Consumer Safety Act, a crucial piece of legislation that addresses the pressing need for FDA regulation of CBD.
“This bill provides a much needed pathway for FDA to establish a clear and consistent framework for the production, marketing, and sale of hemp-derived CBD to ensure consumer safety while fostering a thriving, regulated market. We look forward to supporting his efforts and appreciate his longtime commitment to unlocking the full potential of the hemp industry.”
The Hemp Access and Consumer Safety Act of 2023 is also being endorsed by national advocacy organizations including We Are For Better Alternatives (WAFBA), the American Herbal Products Association (AHPA), the Hemp Industries Association (HIA), National Hemp Growers Association, Realm of Caring, U.S. Hemp Authority (USHA) and Veterinary Cannabis Society, along with regional and state-based groups such as the Midwest Hemp Council, Colorado Hemp Association, Kentucky Hemp Association, Georgia Hemp Association, iHemp Michigan, South Dakota Industrial Hemp Association, and the Virginia Hemp Coalition.
